Literature DB >> 17530854

The active form of Chlamydia trachomatis ribonucleotide reductase R2 protein contains a heterodinuclear Mn(IV)/Fe(III) cluster with S = 1 ground state.

Wei Jiang1, J Martin Bollinger, Carsten Krebs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17530854      PMCID： PMC3870001          DOI： 10.1021/ja072528a

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  18 in total

Review 1.  Ribonucleotide reductases: the link between an RNA and a DNA world?

Authors:  J Stubbe
Journal:  Curr Opin Struct Biol       Date:  2000-12       Impact factor: 6.809

Review 2.  Seven clues to the origin and structure of class-I ribonucleotide reductase intermediate X.

Authors:  Wen-Ge Han; Tiqing Liu; Timothy Lovell; Louis Noodleman
Journal:  J Inorg Biochem       Date:  2006-02-28       Impact factor: 4.155

Review 3.  Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer?

Authors:  JoAnne Stubbe; Daniel G Nocera; Cyril S Yee; Michelle C Y Chang
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

4.  Active site of ribonucleoside diphosphate reductase from Escherichia coli. Inactivation of the enzyme by 2'-substituted ribonucleoside diphosphates.

Authors:  L Thelander; B Larsson
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

5.  Cloning and characterization of ribonucleotide reductase from Chlamydia trachomatis.

Authors:  C Roshick; E R Iliffe-Lee; G McClarty
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 6.  Di-iron-tyrosyl radical ribonucleotide reductases.

Authors:  JoAnne Stubbe
Journal:  Curr Opin Chem Biol       Date:  2003-04       Impact factor: 8.822

7.  Spectroscopic and computational evaluation of the structure of the high-spin Fe(IV)-oxo intermediates in taurine: alpha-ketoglutarate dioxygenase from Escherichia coli and its His99Ala ligand variant.

Authors:  Sebastian Sinnecker; Nina Svensen; Eric W Barr; Shengfa Ye; J Martin Bollinger; Frank Neese; Carsten Krebs
Journal:  J Am Chem Soc       Date:  2007-04-24       Impact factor: 15.419

8.  Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme.

Authors:  C L Atkin; L Thelander; P Reichard; G Lang
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

9.  Mechanism-based inhibition of a mutant Escherichia coli ribonucleotide reductase (cysteine-225----serine) by its substrate CDP.

Authors:  S S Mao; M I Johnston; J M Bollinger; J Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Thiyl radicals in ribonucleotide reductases.

Authors:  S Licht; G J Gerfen; J Stubbe
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728
View more
  25 in total

1.  O(2)-evolving chlorite dismutase as a tool for studying O(2)-utilizing enzymes.

Authors:  Laura M K Dassama; Timothy H Yosca; Denise A Conner; Michael H Lee; Béatrice Blanc; Bennett R Streit; Michael T Green; Jennifer L DuBois; Carsten Krebs; J Martin Bollinger
Journal:  Biochemistry       Date:  2012-02-13       Impact factor: 3.162

2.  Mössbauer properties of the diferric cluster and the differential iron(II)-binding affinity of the iron sites in protein R2 of class Ia Escherichia coli ribonucleotide reductase: a DFT/electrostatics study.

Authors:  Wen-Ge Han; Gregory M Sandala; Debra Ann Giammona; Donald Bashford; Louis Noodleman
Journal:  Dalton Trans       Date:  2011-08-12       Impact factor: 4.390

3.  EXAFS simulation refinement based on broken-symmetry DFT geometries for the Mn(IV)-Fe(III) center of class I RNR from Chlamydia trachomatis.

Authors:  Sandra Luber; Sophie Leung; Carmen Herrmann; Wenge Han Du; Louis Noodleman; Victor S Batista
Journal:  Dalton Trans       Date:  2014-01-14       Impact factor: 4.390

4.  Two-Color Valence-to-Core X-ray Emission Spectroscopy Tracks Cofactor Protonation State in a Class I Ribonucleotide Reductase.

Authors:  Ryan J Martinie; Elizabeth J Blaesi; J Martin Bollinger; Carsten Krebs; Kenneth D Finkelstein; Christopher J Pollock
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-04       Impact factor: 15.336

5.  Evidence for a Di-μ-oxo Diamond Core in the Mn(IV)/Fe(IV) Activation Intermediate of Ribonucleotide Reductase from Chlamydia trachomatis.

Authors:  Ryan J Martinie; Elizabeth J Blaesi; Carsten Krebs; J Martin Bollinger; Alexey Silakov; Christopher J Pollock
Journal:  J Am Chem Soc       Date:  2017-01-27       Impact factor: 15.419

6.  Evidence that the β subunit of Chlamydia trachomatis ribonucleotide reductase is active with the manganese ion of its manganese(IV)/iron(III) cofactor in site 1.

Authors:  Laura M K Dassama; Amie K Boal; Carsten Krebs; Amy C Rosenzweig; J Martin Bollinger
Journal:  J Am Chem Soc       Date:  2012-01-25       Impact factor: 15.419

Review 7.  Assembly of nonheme Mn/Fe active sites in heterodinuclear metalloproteins.

Authors:  Julia J Griese; Vivek Srinivas; Martin Högbom
Journal:  J Biol Inorg Chem       Date:  2014-04-26       Impact factor: 3.358

8.  Electron hopping through proteins.

Authors:  Jeffrey J Warren; Maraia E Ener; Antonín Vlček; Jay R Winkler; Harry B Gray
Journal:  Coord Chem Rev       Date:  2012-04-05       Impact factor: 22.315

9.  Radical-translocation intermediates and hurdling of pathway defects in "super-oxidized" (Mn(IV)/Fe(IV)) Chlamydia trachomatis ribonucleotide reductase.

Authors:  Laura M K Dassama; Wei Jiang; Paul T Varano; Maria-Eirini Pandelia; Denise A Conner; Jiajia Xie; J Martin Bollinger; Carsten Krebs
Journal:  J Am Chem Soc       Date:  2012-12-04       Impact factor: 15.419

10.  Novel Approaches for the Accumulation of Oxygenated Intermediates to Multi-Millimolar Concentrations.

Authors:  Carsten Krebs; Laura M K Dassama; Megan L Matthews; Wei Jiang; John C Price; Victoria Korboukh; Ning Li; J Martin Bollinger
Journal:  Coord Chem Rev       Date:  2013-01-01       Impact factor: 22.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.